text stringlengths 1 5.46k |
|---|
Investors: |
Laurence Watts, Gilmartin Group, LLC.: |
619-916-7620 |
laurence@gilmartinir.com |
AbbVie |
Media: |
Adelle Infante |
847-938-8745 |
adelle.infante@abbvie.com |
Investors: |
Liz Shea |
847-935-2211 |
liz.shea@abbvie.com |
Source: Alpine Immune Sciences Inc.; AbbVie Inc. |
Schedule 10.2 |
Licensor Disclosure Schedule |
Section 10.2.2 The Identified Patent described in Schedule 6.6.3(c) (Special Offset). |
Schedule 10.2.1 |
Existing Licensor Product Patents |
AIS Family No. 03 Attorney Reference No. 76161.x0003.xx ICOS LIGAND VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF |
Country Atty. Ref. Application No. (Country Filing Date) Publication No. (Publication Date) Status and Comments |
US 30003.00 62/323,608 (4/15/2016) None Expired |
US 30003.01 62/394,745 (9/14/2016) None Expired |
US 30003.02 62/410,842 (10/20/2016) None Expired |
US 30003.03 62/472,568 (3/16/2017) None Expired |
US 30003.04 62/475,162 (3/22/2017) None Expired |
PCT 20003.40 PCT/US2017/027811 (4/14/2017) WO 2017/181148 (10/19/2017) Expired; Nat'l phase filed |
AU 20003.41 2017250358 (9/26/2018) AU-A-2017250358 (10/18/2018) Pending |
BR 20003.42 BR 11 2018 070934 4 (10/10/2018) BR1120180709344 (2/26/2019) Pending |
CA 20003.43 3,019,199 (9/26/2018) CA 3019199 (10/04/2018) Pending |
CN 20003.44 201780036984.0 (12/13/2018) CN 110088126 (08/02/2019) Pending |
EA 20003.45 201892336 (11/14/2018) EA 201892336 (06/28/2019) Pending |
EP 20003.46 17733114.7 (9/28/2018) EP 3442999 (02/20/2019) Pending |
IL 20003.47 262365 (10/14/2018) IL 262365 (11/29/2018) Pending |
IN 20003.48 201817041129 (10/31/2018) IN 201817041129 (03/01/2019) Pending |
JP 20003.49 2018-554101 (12/10/2018) JP 2019514361 (06/06/2019) Pending |
KR 20003.50 10-2018-7033049 (11/14/2018) KR 20190005879 (01/16/2019) Pending |
MX 20003.51 MX/a/2018/012472 (10/11/2018) MX/a/2018/012472 (09/06/2019) Pending |
NZ 20003.52 746741 (9/26/2018) NZ 746741 A1 (09/28/2019) Pending |
SG 20003.53 11201808457P (9/27/2018) SG 11201808457P (10/30/2018) Pending |
HK (EP) 20003.54 19121707.4 (4/1/2019) HK 1261801 (1/3/2020) Pending |
HK (CN) 20003.55 19128847.1 (8/28/2019) Not yet published Pending |
US 20003.00 15/488409 (04/14/2017) US 2017/0320959 (11/9/2017) Pending |
AIS Family No. 07 |
MULTI-DOMAIN IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF Country Atty. Ref. Application No. (Country Filing Date) Publication No. (Publication Date) Status and Comments |
US 30007.00 62/613,378 (01/03/2018) None Expired |
US 30007.01 62/733,622 (09/19/2018) None Expired |
PCT 20007.40 PCT/US2019/012222 (01/03/2019) WO 2019/136179 (07/11/2019) Pending |
AIS Family No. 12 Attorney Reference No. 76161.x0022.xx VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS |
Country Atty. Ref. Application No. (Country Filing Date) Publication No. (Publication Date) Status and Comments |
US 30022.00 62/574,161 (10/18/2017) None Expired |
AR 20022.41 20180103041 (10/18/2018) None Pending |
TW 20022.42 107136610 (10/17/2018) 201925223 (07/01/2019) Pending |
PCT 20022.40 PCT/US2018/056381 (10/17/2018) WO 2019/079520 (04/25/2019) Expired; Nat'l phase filed by 18 April 2020 |
AU 20022.43 2018351000 (4/9/2020) AU-A1-2018351000 (04/30/2020) Pending |
BR 20022.44 BR 11 2020 007542 6 (4/16/2020) Not yet published Pending |
CA 20022.45 3,078,517 (4/3/2020) CA 3078517 A1 (04/25/2019) Pending |
CN 20022.46 Not yet available Not yet published Pending |
EA 20022.47 202090974 (05/15/2020) Not yet published Pending |
EP 20022.48 18803814.5 (4/1/2020) Not yet published Pending |
IL 20022.49 273726 (3/31/2020) Not yet published Pending |
IN 20022.50 20201701941 (05/07/2020) Not yet published Pending |
JP 20022.51 2020-521877(4/17/2020) Not yet published Pending |
KR 20022.52 Not yet available Not yet published Pending |
MX 20022.53 MX/a/2020/004540 (4/30/2020) Not yet published Pending |
NZ 20022.54 763426 (4/9/2020) Not yet published Pending |
SG 20022.55 11202003078V (4/2/2020) Not yet published Pending |
UAE 20022.56 P6000549/20 (4/15/2020) Not yet published Pending |
BH 20022.57 20200069 (4/16/2020) Not yet published Pending |
MY 20022.60 PI2020001960 (4/18/2020) Not yet published Pending |
PH 20022.62 Not yet available Not yet published Pending |
QA 20022.63 QA/202004/00202 (4/15/2020) Not yet published Pending |
SA 20022.64 520411779 (4/16/2020) Not yet published Pending |
UA 20022.66 a202002918 (5/15/2020) Not yet published Pending |
ZA 20022.67 2020/02826 (5/15/2020) Not yet published Pending |
US 20022.00 16/757,344 (4/17/2020) Not yet published Pending |
AIS Family No. 20 Attorney Reference No. 76161.x0032.xx METHODS AND USES OF VARIANT ICOS LIGAND (ICOSL) FUSION PROTEINS |
Country Atty. Ref. Application No. (Country Filing Date) Publication No. (Publication Date) Status and Comments |
US 30032.00 62/635488 (04/17/2019) None Expired |
US 30032.01 62/855830 (5/31/2019) None Pending |
US 30032.02 62/931212 (11/5/2019) None Pending |
US 30032.03 62/945071 (12/06/2019) None Pending |
US 30032.04 62/962,832 (01/17/2020) None Pending |
US 30032.05 62/987,854 (03/10/2020) None Pending |
PCT 20032.40 PCT/US2020/028601 (4/16/2020) Not yet published Pending |
Schedule 13.1 |
Approved Third Party Providers |
Current Potential for future Clinical - HV Nucleus Network/CPR, Covance, or QPS Clinical - SLE N/A IQVIA, PRA or Parexel |
Nonclinical CRL |
Clinical BioA PPD, 360Biolabs and/or PRA, Northwest Pk Solutions |
Toxicology |
Toxicology Alta Biosciences |
Regulatory |
Reg Ops Pharmaceutical eConsulting, Accenture, Acuta, BDO |
EU Reg RegIntel, Voisin, Jenkins & Jenkins, Ltd. |
Other Reg ICON (Mapi Group), Parexel |
INN Brand Institute |
Biomarkers |
Flow In-house, 360biolabs Q2 |
CMC |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.